The full text of this article hosted at iucr.org is unavailable due to technical difficulties. Original Article Sustained Long‐Term Efficacy and Safety of Adalimumab in Pediatric Patients with Severe Chronic Plaque Psoriasis from a Randomised, Double‐Blind, Phase 3 Study D. Thaçi Corresponding Author E-mail address: Diamant.Thaci@uksh.de Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany Corresponding author Diamant Thaçi, Prof.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile